Trastuzumab triggers phagocytic killing of high HER2 cancer cells in vitro and in vivo by interaction with Fcγ receptors on macrophages

The Journal of Immunology : Official Journal of the American Association of Immunologists
Yun ShiZhiqiang An

Abstract

Trastuzumab has been used for the treatment of HER2-overexpressing breast cancer for more than a decade, but the mechanisms of action for the therapy are still being actively investigated. Ab-dependent cell-mediated cytotoxicity mediated by NK cells is well recognized as one of the key mechanisms of action for trastuzumab, but trastuzumab-mediated Ab-dependent cellular phagocytosis (ADCP) has not been established. In this study, we demonstrate that macrophages, by way of phagocytic engulfment, can mediate ADCP and cancer cell killing in the presence of trastuzumab. Increased infiltration of macrophages in the tumor tissue was associated with enhanced efficacy of trastuzumab whereas depletion of macrophages resulted in reduced antitumor efficacy in mouse xenograft tumor models. Among the four mouse FcγRs, FcγRIV exhibits the strongest binding affinity to trastuzumab. Knockdown of FcγRIV in mouse macrophages reduced cancer cell killing and ADCP activity triggered by trastuzumab. Consistently, an upregulation of FcγRIV expression by IFN-γ triggered an increased ADCP activity by trastuzumab. In an analogous fashion, IFN-γ priming of human macrophages increased the expression of FcγRIII, the ortholog of murine FcγRIV, and increased ...Continue Reading

References

Jan 1, 1992·Immunologic Research·M W Fanger, D V Erbe
Jan 1, 1996·Annual Review of Cell and Developmental Biology·M Raghavan, P J Bjorkman
Mar 31, 2000·Nature Medicine·R A ClynesJ V Ravetch
Aug 3, 2002·Nature Reviews. Immunology·Toshiyuki Takai
Oct 22, 2002·Immunogenetics·Ludmila V MechetinaAlexander V Taranin
Jul 26, 2005·Immunity·Falk NimmerjahnJeffrey V Ravetch
Dec 3, 2005·Science·Falk Nimmerjahn, Jeffrey V Ravetch
Mar 8, 2006·The Journal of Experimental Medicine·Yasuhito HamaguchiThomas F Tedder
Mar 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Greg A LazarBassil I Dahiyat
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Minna TaskinenSirpa Leppä
Oct 3, 2007·Blood·Ezogelin OflazogluHans-Peter Gerber
Mar 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonino MusolinoAndrea Ardizzoni
May 20, 2008·Journal of Translational Medicine·Alessandra BeanoLina Matera
Aug 30, 2008·Molecular Cancer Therapeutics·John O RichardsJohn R Desjarlais
Nov 5, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marielle A OttenMarjolein van Egmond
Mar 12, 2009·Cancer Research·Murli NarayanNita J Maihle
Mar 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marzia LeidiJosée Golay
Oct 27, 2010·Proceedings of the National Academy of Sciences of the United States of America·Falk NimmerjahnJeffrey V Ravetch
Jan 1, 2008·CSH Protocols·Joachim Weischenfeldt, Bo Porse
Oct 30, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katharine D GruganRandall J Brezski
Jan 22, 2014·Nature Reviews. Immunology·Martin GuilliamsBart N Lambrecht

❮ Previous
Next ❯

Citations

Jan 15, 2016·Blood·Stephen A BeersAnn L White
Oct 26, 2016·Journal for Immunotherapy of Cancer·Sasha E Stanton, Mary L Disis
Feb 7, 2017·The Breast : Official Journal of the European Society of Mastology·Mary L Disis, Sasha E Stanton
Dec 7, 2017·Oncoimmunology·Abhishek D GargLorenzo Galluzzi
Feb 7, 2018·Disease Markers·Martina Di ModicaTiziana Triulzi
Nov 28, 2018·British Journal of Cancer·Tiziana TriulziElda Tagliabue
Sep 25, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Kyungyeol PaekJae Hee Lee
Mar 12, 2020·Immunology and Cell Biology·Alicia M ChenowethP Mark Hogarth
Aug 20, 2019·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Ran LiMiles A Miller
Oct 27, 2015·Immunological Reviews·Lekh N DahalMark S Cragg
Jan 25, 2017·Nature Reviews. Clinical Oncology·Alberto MantovaniPaola Allavena
Dec 7, 2018·Cell Death & Disease·Sanjeev Kumar SagwalSander Bekeschus
Aug 20, 2017·Protein & Cell·William R Strohl
Jul 31, 2019·Scientific Reports·Tiia J HonkanenJussi P Koivunen
Apr 20, 2019·International Journal of Molecular Sciences·Benedetto SacchettiMaurizio Alimandi
Dec 14, 2018·Oncoimmunology·Tiziana TriulziElda Tagliabue
Oct 21, 2019·Journal of Biomedical Science·Yibing ChenZhengzhi Zou
Sep 30, 2017·Frontiers in Immunology·Kristina M IlievaSophia N Karagiannis
Aug 4, 2020·Expert Opinion on Therapeutic Targets·Stamatios TheocharisJerzy Klijanienko
Jun 2, 2018·Cancer Immunology, Immunotherapy : CII·Jun YinJohn O Richards
May 3, 2019·Cancer Immunology Research·Sangeetha M ReddyElizabeth A Mittendorf
May 27, 2016·Molecular Cancer Therapeutics·Ramraj VelmuruganE Sally Ward
Apr 15, 2018·Molecular Cancer Therapeutics·Ahmed T KurdiIrene M Ghobrial
Dec 19, 2020·Cancer Cell·Giulia PetroniLorenzo Galluzzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.